Chronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplasms or Clonal Evolution With Isotype Switch?
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqac165 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Yue Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, B-Lymphocytes, Clonal Evolution, Immunoglobulin Light Chains. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate clinicopathologic characteristics of biclonal chronic lymphocytic leukemia (CLL).
Methods
Retrospectively analyze clinical data and pathologic features.
Results
Ten cases were identified in which flow cytometry demonstrated an abnormal B-cell population with a CLL-like immunophenotype but showed no definitive light chain restriction. All had cytogenetic abnormalities detected, including seven with two CLL-related abnormalities. Four of these showed features suggestive of clonal evolution, all having del(13q) as a “stem-line” abnormality and three showing del(11q) as a “side-line” abnormality. Five (50%) cases demonstrated deleterious NOTCH1 mutations, in contrast to 11.8% in a control group of monoclonal CLL (P < .05). Of the 10 patients, 5 received treatment, with good/partial response in three cases and therapeutic resistance in one case. The median treatment-free survival was estimated at 68 months.
Conclusions
Despite a polytypic pattern of light chain expression, the neoplastic nature of biclonal CLL is suggested by a characteristic CLL phenotype and can be confirmed by cytogenetic and genomic analyses. The two clones with discordant light chain isotypes may share a “stem-line” cytogenetic abnormality, suggesting possible clonal evolution. Biclonal CLL is associated with NOTCH1 mutations, which may occur in a small subclone and gradually evolve in clonal size. Genomic analysis on light chain–sorted and/or chronologically collected samples may provide insight into clonal evolution in CLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
- Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Endi Wang
Zitieren
APA
Zhao, Y., Siddiqi, I., Wildes, T. J., McCracken, J., Deak, K., Rehder, C., & Wang, E. (2023). Chronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplasms or Clonal Evolution With Isotype Switch?. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac165
Vancouver
Zhao Y, Siddiqi I, Wildes TJ, McCracken J, Deak K, Rehder C, et al. Chronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplasms or Clonal Evolution With Isotype Switch?. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac165
BibTeX
@article{Zhao2023,
author = {Zhao, Yue and Siddiqi, Imran and Wildes, Tyler J and McCracken, Jenna and Deak, Kristen and Rehder, Catherine and Wang, Endi},
title = {Chronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplasms or Clonal Evolution With Isotype Switch?},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqac165}
}
EUVIMED